Literature DB >> 2293874

Pathogenesis of vertebral metastasis and epidural spinal cord compression.

F Arguello1, R B Baggs, R E Duerst, L Johnstone, K McQueen, C N Frantz.   

Abstract

The authors have studied the sequential events in the process of vertebral metastasis that result in spinal cord compression. Different tumor cell lines were injected into the systemic arterial circulation of syngeneic or nude mice, and they were killed at timed intervals after injection or when they became paraplegic. The following observations were made. The tumor cells lodged and grew in the hematopoietic bone marrow of the vertebrae. Cancer cells in the vertebral marrow cavity invaded into the spinal canal through the foramina of the vertebral veins rather than destroying the cortical bone. Tumor cell lines that grew in an infiltrative fashion migrated toward a posterior location in the spinal canal, and compressed the spinal cord from a posterior direction. Tumor cell lines that grew as compact tumors formed a tumor mass at the same location from which the cells emerged from the vertebra, and compressed the cord predominantly from an anterior direction. Radiographic evidence of vertebral metastasis was a late event, and commonly associated with significant compression of the cord and extraosseous tumor. These experimental findings may help to establish better diagnostic and treatment strategies for patients with metastatic disease of the spine.

Entities:  

Mesh:

Year:  1990        PMID: 2293874     DOI: 10.1002/1097-0142(19900101)65:1<98::aid-cncr2820650121>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Pattern of Tumour Spread of Common Primary Tumours as Seen on Magnetic Resonance Imaging.

Authors:  David Laszlo Tarnoki; Adam Domonkos Tarnoki; Susanne Ohlmann-Knafo; Dirk Pickuth
Journal:  Pathol Oncol Res       Date:  2015-08-30       Impact factor: 3.201

Review 2.  Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence.

Authors:  Zach Pennington; A Karim Ahmed; Camilo A Molina; Jeffrey Ehresman; Ilya Laufer; Daniel M Sciubba
Journal:  Ann Transl Med       Date:  2018-03

Review 3.  The use of radiation in the management of spinal metastases.

Authors:  C M Faul; J C Flickinger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 4.  Metastasis to nervous system: spinal epidural and intramedullary metastases.

Authors:  Melike Mut; David Schiff; Mark E Shaffrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

5.  An in vivo mouse model of intraosseous spinal cancer causing evolving paraplegia.

Authors:  Davina A F Cossigny; Effie Mouhtouris; Sathana Dushyanthen; Augusto Gonzalvo; Gerald M Y Quan
Journal:  J Neurooncol       Date:  2013-08-18       Impact factor: 4.130

6.  Characterization of brain and bone-metastasizing clones selected from an ethylnitrosourea-induced rat mammary carcinoma.

Authors:  D G Hall; G Stoica
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

7.  Establishing a rabbit spinal tumor model for nonvascular interventional therapy through CT-guided percutaneous puncture inoculation.

Authors:  L Chen; J Xiao; I-C Su; Y-W Wu; B Zhang; K-Y Ge; Y-C Chang; C Yang; C-F Ni
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

8.  [Surgical management of vertebral column metastatic disease].

Authors:  K-D Schaser; I Melcher; T Mittlmeier; A Schulz; J H Seemann; N P Haas; A C Disch
Journal:  Unfallchirurg       Date:  2007-02       Impact factor: 1.000

9.  Complications in the management of metastatic spinal disease.

Authors:  Eilis Catherine Dunning; Joseph Simon Butler; Seamus Morris
Journal:  World J Orthop       Date:  2012-08-18

10.  Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases.

Authors:  E Amir; C Whyne; O C Freedman; M Fralick; R Kumar; M Hardisty; M Clemons
Journal:  Clin Exp Metastasis       Date:  2009-03-06       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.